nach oben

Inflammation

Erschienen in:

11.05.2020 | Original Article

CD200R Is Involved in the Anti-inflammatory Effect of Dexmedetomidine in Lipopolysaccharide-Stimulated Microglia

verfasst von: Xiaobao Zhang, Jizheng Cui, Haitao Qian, Bing Wang, Fang Yan, Zhibin Zhao

Erschienen in: Inflammation | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Dexmedetomidine has been confirmed to have anti-inflammatory effect in numerous diseases. However, the detailed mechanism is still unknown. We explore the hypothesis that CD200R is related to the anti-inflammatory effect of dexmedetomidine. Primary microglia were treated with different concentrations of dexmedetomidine followed with lipopolysaccharide (LPS) for 24 h. Interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interleukin-10 (IL-10) were measured by enzyme-linked immunosorbent assay. Arginase 1 (Arg1), IL-6, and TNF-α were measured by TR-PCR. CD200R was observed by Western blot analysis. We found dexmedetomidine reduced LPS-induced IL-6 and TNF-α production and increase Arg1 in primary microglia. CD200R expression was downregulated by LPS and dexmedetomidine can attenuate the effect of LPS. Our results showed that CD200R may be related to the anti-inflammatory effect of dexmedetomidine.

Andreu-Sanchez, C., M.A. Martin-Pascual, A. Gruart, and J.M. Delgado-Garcia. 2018. Chaotic and fast audiovisuals increase attentional scope but decrease conscious processing. Neuroscience 394: 83–97. https://doi.org/10.1016/j.neuroscience.2018.10.025.CrossRefPubMed

Carr, Z.J., T.J. Cios, K.F. Potter, and J.T. Swick. 2018. Does Dexmedetomidine ameliorate postoperative cognitive dysfunction? A brief review of the recent literature. Current Neurology and Neuroscience Reports 18 (10): 64. https://doi.org/10.1007/s11910-018-0873-z.CrossRefPubMed

Comella Bolla, A., T. Valente, A. Miguez, V. Brito, S. Gines, C. Sola, M. Straccia, and J.M. Canals. 2019. CD200 is up-regulated in R6/1 transgenic mouse model of Huntington's disease. PLoS One 14 (12): e0224901. https://doi.org/10.1371/journal.pone.0224901.CrossRefPubMedPubMedCentral

Dentesano, G., M. Straccia, A. Ejarque-Ortiz, J.M. Tusell, J. Serratosa, J. Saura, and C. Sola. 2012. Inhibition of CD200R1 expression by C/EBP beta in reactive microglial cells. Journal of Neuroinflammation 9: 165. https://doi.org/10.1186/1742-2094-9-165.CrossRefPubMedPubMedCentral

Dentesano, G., J. Serratosa, J.M. Tusell, P. Ramon, T. Valente, J. Saura, and C. Sola. 2014. CD200R1 and CD200 expression are regulated by PPAR-gamma in activated glial cells. Glia 62 (6): 982–998. https://doi.org/10.1002/glia.22656.CrossRefPubMed

Fonken, L.K., M.D. Weber, R.A. Daut, M.M. Kitt, M.G. Frank, L.R. Watkins, and S.F. Maier. 2016. Stress-induced neuroinflammatory priming is time of day dependent. Psychoneuroendocrinology 66: 82–90. https://doi.org/10.1016/j.psyneuen.2016.01.006.CrossRefPubMedPubMedCentral

Frank, M.G., L.K. Fonken, J.L. Annis, L.R. Watkins, and S.F. Maier. 2018. Stress disinhibits microglia via down-regulation of CD200R: A mechanism of neuroinflammatory priming. Brain, Behavior, and Immunity 69: 62–73. https://doi.org/10.1016/j.bbi.2017.11.001.CrossRefPubMed

Hoek, R.M., S.R. Ruuls, C.A. Murphy, G.J. Wright, R. Goddard, S.M. Zurawski, B. Blom, et al. 2000. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290 (5497): 1768–1771. https://doi.org/10.1126/science.290.5497.1768.CrossRefPubMed

Jakob, S.M., E. Ruokonen, R.M. Grounds, T. Sarapohja, C. Garratt, S.J. Pocock, J.R. Bratty, J. Takala, and Investigators Dexmedetomidine for Long-Term Sedation. 2012. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA 307 (11): 1151–1160. https://doi.org/10.1001/jama.2012.304.CrossRefPubMed

10.

Jenmalm, M.C., H. Cherwinski, E.P. Bowman, J.H. Phillips, and J.D. Sedgwick. 2006. Regulation of myeloid cell function through the CD200 receptor. Journal of Immunology 176 (1): 191–199. https://doi.org/10.4049/jimmunol.176.1.191.CrossRef

11.

Kawazoe, Y., K. Miyamoto, T. Morimoto, T. Yamamoto, A. Fuke, A. Hashimoto, H. Koami, et al. 2017. Effect of dexmedetomidine on mortality and ventilator-free days in patients requiring mechanical ventilation with Sepsis: a randomized clinical trial. JAMA 317 (13): 1321–1328. https://doi.org/10.1001/jama.2017.2088.CrossRefPubMedPubMedCentral

12.

Kern, K., S. Pierre, Y. Schreiber, C. Angioni, D. Thomas, N. Ferreiros, G. Geisslinger, and K. Scholich. 2017. CD200 selectively upregulates prostaglandin E2 and D2 synthesis in LPS-treated bone marrow-derived macrophages. Prostaglandins & Other Lipid Mediators 133: 53–59. https://doi.org/10.1016/j.prostaglandins.2017.06.002.CrossRef

13.

Kong, W., K. Kang, Y. Gao, H. Liu, X. Meng, S. Yang, K. Yu, and M. Zhao. 2017. Dexmedetomidine alleviates LPS-induced septic cardiomyopathy via the cholinergic anti-inflammatory pathway in mice. American Journal of Translational Research 9 (11): 5040–5047.PubMedPubMedCentral

14.

Li, B., Y. Li, S. Tian, H. Wang, H. Wu, A. Zhang, and C. Gao. 2015. Anti-inflammatory effects of perioperative dexmedetomidine administered as an adjunct to general anesthesia: a meta-analysis. Scientific Reports 5: 12342. https://doi.org/10.1038/srep12342.CrossRefPubMedPubMedCentral

15.

Liu, Y., M. Li, Z. Zhang, Y. Ye, and J. Zhou. 2018. Role of microglia-neuron interactions in diabetic encephalopathy. Ageing Research Reviews 42: 28–39. https://doi.org/10.1016/j.arr.2017.12.005.CrossRefPubMed

16.

Lyons, A., E.J. Downer, D.A. Costello, N. Murphy, and M.A. Lynch. 2012. Dok2 mediates the CD200Fc attenuation of Abeta-induced changes in glia. Journal of Neuroinflammation 9: 107. https://doi.org/10.1186/1742-2094-9-107.CrossRefPubMedPubMedCentral

17.

Manich, G., M. Recasens, T. Valente, B. Almolda, B. Gonzalez, and B. Castellano. 2019. Role of the CD200-CD200R axis during homeostasis and neuroinflammation. Neuroscience 405: 118–136. https://doi.org/10.1016/j.neuroscience.2018.10.030.CrossRefPubMed

18.

Masocha, W. 2009. Systemic lipopolysaccharide (LPS)-induced microglial activation results in different temporal reduction of CD200 and CD200 receptor gene expression in the brain. Journal of Neuroimmunology 214 (1-2): 78–82. https://doi.org/10.1016/j.jneuroim.2009.06.022.CrossRefPubMed

19.

Mihrshahi, R., A.N. Barclay, and M.H. Brown. 2009. Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells. Journal of Immunology 183 (8): 4879–4886. https://doi.org/10.4049/jimmunol.0901531.CrossRef

20.

Sanchez, A., C. Thomas, F. Deeken, S. Wagner, S. Kloppel, F. Kentischer, C.A.F. von Arnim, et al. 2019. Patient safety, cost-effectiveness, and quality of life: reduction of delirium risk and postoperative cognitive dysfunction after elective procedures in older adults-study protocol for a stepped-wedge cluster randomized trial (PAWEL Study). Trials 20 (1): 71. https://doi.org/10.1186/s13063-018-3148-8.CrossRefPubMedPubMedCentral

21.

Shi, C., J. Jin, L. Qiao, T. Li, J. Ma, and Z. Ma. 2019. Effect of perioperative administration of dexmedetomidine on delirium after cardiac surgery in elderly patients: A double-blinded, multi-center, randomized study. Clinical Interventions in Aging 14: 571–575. https://doi.org/10.2147/CIA.S194476.CrossRefPubMedPubMedCentral

22.

Stephenson, J., E. Nutma, P. van der Valk, and S. Amor. 2018. Inflammation in CNS neurodegenerative diseases. Immunology 154 (2): 204–219. https://doi.org/10.1111/imm.12922.CrossRefPubMedPubMedCentral

23.

Subramaniam, B., P. Shankar, S. Shaefi, A. Mueller, B. O'Gara, V. Banner-Goodspeed, J. Gallagher, et al. 2019. Effect of intravenous acetaminophen vs placebo combined with propofol or dexmedetomidine on postoperative delirium among older patients following cardiac surgery: the DEXACET randomized clinical trial. JAMA 321 (7): 686–696. https://doi.org/10.1001/jama.2019.0234.CrossRefPubMedPubMedCentral

24.

Sun, Z., T. Zhao, S. Lv, Y. Gao, J. Masters, and H. Weng. 2018. Dexmedetomidine attenuates spinal cord ischemia-reperfusion injury through both anti-inflammation and anti-apoptosis mechanisms in rabbits. Journal of Translational Medicine 16 (1): 209. https://doi.org/10.1186/s12967-018-1583-7.CrossRefPubMedPubMedCentral

25.

Vilalta, A., and G.C. Brown. 2018. Neurophagy, the phagocytosis of live neurons and synapses by glia, contributes to brain development and disease. The FEBS Journal 285 (19): 3566–3575. https://doi.org/10.1111/febs.14323.CrossRefPubMed

26.

Wang, J. 2010. Preclinical and clinical research on inflammation after intracerebral hemorrhage. Progress in Neurobiology 92 (4): 463–477. https://doi.org/10.1016/j.pneurobio.2010.08.001.CrossRefPubMedPubMedCentral

27.

Wang, J., Y. Song, Z. Chen, and S.X. Leng. 2018. Connection between systemic inflammation and neuroinflammation underlies neuroprotective mechanism of several phytochemicals in neurodegenerative diseases. Oxidative Medicine and Cellular Longevity 2018: 1972714. https://doi.org/10.1155/2018/1972714.CrossRefPubMedPubMedCentral

28.

Xia, L., X. Xie, Y. Liu, and X. Luo. 2017. Peripheral blood monocyte tolerance alleviates intraperitoneal lipopolysaccharides-induced neuroinflammation in rats via upregulating the CD200R expression. Neurochemical Research 42 (11): 3019–3032. https://doi.org/10.1007/s11064-017-2334-5.CrossRefPubMed

29.

Xia, Z.N., Y. Zong, Z.T. Zhang, J.K. Chen, X.J. Ma, Y.G. Liu, L.J. Zhao, and G.C. Lu. 2017. Dexmedetomidine protects against multi-organ dysfunction induced by heatstroke via sustaining the intestinal integrity. Shock 48 (2): 260–269. https://doi.org/10.1097/SHK.0000000000000826.CrossRefPubMed

30.

Yang, W., L.S. Kong, X.X. Zhu, R.X. Wang, Y. Liu, and L.R. Chen. 2019. Effect of dexmedetomidine on postoperative cognitive dysfunction and inflammation in patients after general anaesthesia: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 98 (18): e15383. https://doi.org/10.1097/MD.0000000000015383.CrossRef

31.

Yi, M.H., E. Zhang, J.J. Kim, H. Baek, N. Shin, S. Kim, S.R. Kim, et al. 2016. CD200R/Foxp3-mediated signalling regulates microglial activation. Scientific Reports 6: 34901. https://doi.org/10.1038/srep34901.CrossRefPubMedPubMedCentral

32.

Zhang, X., J. Wang, W. Qian, J. Zhao, L. Sun, Y. Qian, and H. Xiao. 2014. Dexmedetomidine inhibits tumor necrosis factor-alpha and interleukin 6 in lipopolysaccharide-stimulated astrocytes by suppression of c-Jun N-terminal kinases. Inflammation 37 (3): 942–949. https://doi.org/10.1007/s10753-014-9814-4.CrossRefPubMed

33.

Zhang, X., J. Wang, W. Qian, J. Zhao, L. Sun, Y. Qian, and H. Xiao. 2015. Dexmedetomidine inhibits inducible nitric oxide synthase in lipopolysaccharide-stimulated microglia by suppression of extracellular signal-regulated kinase. Neurological Research 37 (3): 238–245. https://doi.org/10.1179/1743132814Y.0000000426.CrossRefPubMed

34.

Zhang, H., Z. Wu, X. Zhao, and Y. Qiao. 2018. Role of dexmedetomidine in reducing the incidence of postoperative cognitive dysfunction caused by sevoflurane inhalation anesthesia in elderly patients with esophageal carcinoma. Journal of Cancer Research and Therapeutics 14 (7): 1497–1502. https://doi.org/10.4103/jcrt.JCRT_164_18.CrossRefPubMed

35.

Zhang, X., F. Yan, J. Feng, H. Qian, Z. Cheng, Q. Yang, Y. Wu, Z. Zhao, A. Li, and H. Xiao. 2018. Dexmedetomidine inhibits inflammatory reaction in the hippocampus of septic rats by suppressing NF-kappaB pathway. PLoS One 13 (5): e0196897. https://doi.org/10.1371/journal.pone.0196897.CrossRefPubMedPubMedCentral

36.

Zhang, J., F. Xia, H. Zhao, K. Peng, H. Liu, X. Meng, C. Chen, and F. Ji. 2019. Dexmedetomidine-induced cardioprotection is mediated by inhibition of high mobility group box-1 and the cholinergic anti-inflammatory pathway in myocardial ischemia-reperfusion injury. PLoS One 14 (7): e0218726. https://doi.org/10.1371/journal.pone.0218726.CrossRefPubMedPubMedCentral

37.

Zhao, X., J. Li, and H. Sun. 2019. CD200-CD200R interaction: an important regulator after stroke. Frontiers in Neuroscience 13: 840. https://doi.org/10.3389/fnins.2019.00840.CrossRefPubMedPubMedCentral

Titel: CD200R Is Involved in the Anti-inflammatory Effect of Dexmedetomidine in Lipopolysaccharide-Stimulated Microglia
verfasst von: Xiaobao Zhang
Jizheng Cui
Haitao Qian
Bing Wang
Fang Yan
Zhibin Zhao
Publikationsdatum: 11.05.2020
Verlag: Springer US
Erschienen in: Inflammation / Ausgabe 5/2020
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-020-01244-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

CD200R Is Involved in the Anti-inflammatory Effect of Dexmedetomidine in Lipopolysaccharide-Stimulated Microglia

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2020

Engeletin Attenuates Aβ1–42-Induced Oxidative Stress and Neuroinflammation by Keap1/Nrf2 Pathway

Transcriptome Landscape of Intracellular Brucella ovis Surviving in RAW264.7 Macrophage Immune System

SMILR Aggravates the Progression of Atherosclerosis by Sponging miR-10b-3p to Regulate KLF5 Expression

Anti-inflammatory Effect of Low-Dose Anethole and Ibuprofen Combination Is Accompanied by Partial Prevention of Hepatic Metabolic Changes in Arthritic Rats

Bupropion Ameliorates Acetic Acid–Induced Colitis in Rat: the Involvement of the TLR4/NF-kB Signaling Pathway

Alpinetin Protects Chondrocytes and Exhibits Anti-Inflammatory Effects via the NF-κB/ERK Pathway for Alleviating Osteoarthritis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin